Results 171 to 180 of about 35,572 (277)

Cerebral Fat Embolism Syndrome

open access: yesJournal of the Belgian Society of Radiology, 2019
Vikram Rao Bollineni   +2 more
doaj   +1 more source

Breakdown of C3 complement and IgG in peritonitis exudate-pathophysiological aspects and therapeutic approach [PDF]

open access: yes, 1988
Billing, A.   +5 more
core  

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris   +12 more
wiley   +1 more source

Case report: may-Thurner syndrome: early diagnosis and intervention in a young healthy woman. [PDF]

open access: yesOxf Med Case Reports
Rahman Z   +6 more
europepmc   +1 more source

Rectal metastasis from lung cancer diagnosed by endoscopic ultrasound‐guided fine needle biopsy: A case report

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract A 73‐year‐old man visited our hospital due to hyperintestinal peristalsis and diarrhea. He had been undergoing regular annual checkups for dust lung disease. Contrast‐enhanced computed tomography scan showed edematous thickening of the rectal wall with contrast effect.
Shinji Mukawa   +8 more
wiley   +1 more source

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double‐blind, randomized controlled DHA‐WIN trial

open access: yesInternational Journal of Cancer, Volume 157, Issue 7, Page 1405-1419, 1 October 2025.
What's New? Omega‐3 docosahexaenoic acid (DHA) has shown pleiotropic anti‐cancer effects both in vitro and in animal models. However, clinical evidence of DHA efficacy is limited. This randomized, double‐blind, placebo‐controlled trial tested the efficacy of supplementation with DHA 4.4 g/day during 18 weeks of breast cancer neoadjuvant chemotherapy ...
Jaqueline Munhoz   +16 more
wiley   +1 more source

Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 18, Page 4262-4280, September 2025.
Abstract Background and Purpose The increasing number of cancer survivors has caused growing concern over chemotherapy‐induced cardiotoxicity. This study aimed to investigate a novel human model of cardiotoxicity and explore cardioprotection. Experimental Approach Living myocardial slices (LMS) were obtained from explanted end‐stage heart failure ...
Jort S. A. van der Geest   +15 more
wiley   +1 more source

Atypical presentation of fat embolism syndrome: A case report. [PDF]

open access: yesTrauma Case Rep
Shin SW   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy